Vascular endothelial growth factor (
VEGF)-C is an important lymphangiogenic factor involved in the lymphangiogenesis of gallbladder
carcinoma (GBC) and the
lymph node metastasis of the
tumor.
Tumor necrosis factor (TNF)-α, a key inflammatory
cytokine responding to chronic
inflammation of GBC, has been reported to stimulate the expression of
VEGF-C in some nonneoplastic cells. But whether TNF-α promotes the expression of
VEGF-C in GBC has yet to be determined. Therefore, in the present study, the concentration of TNF-α and
VEGF-C and the lymphatic vessel density (LVD) in the clinical GBC specimens were analyzed, and a linear correlation was found between the concentration of TNF-α and that of
VEGF-C, the lymphatic vessel density (LVD); The transcription and
protein level of
VEGF-C in NOZ cell line were detected by real-time polymerase chain reaction (PCR) and
enzyme linked
immunosorbent assay (ELISA), and TNF-α enhanced the expression of
VEGF-C in NOZ cell lines in a dose and time-dependent manner. Lymphatic tube formation in vitro was observed in a three-dimensional coculture system consisting of HDLECs and NOZ cell lines, and lymphatic vessels of GBC in nude mice model was detected by immunohistochemistry. TNF-α promoted the tube formation of lymphatic endothelial cells in vitro and the lymphangiogenesis of GBC in nude mice; The nuclear factor (NF)-κB binding site on the
VEGF-C promoter was identified using Site-directed mutagenesis, electrophoretic mobility shift assay (EMSA) and
chromatin immunoprecipitation assay (ChIP). Taken together, TNF-α can upregulate the expression of
VEGF-C and promote the lymphangiogenesis of GBC via NF-κB combining with the promoter of
VEGF-C.